When expression is not enough: The evolving thoughts on Fas/FasL and epithelial cell apoptosis

Inflammatory Bowel Diseases

Volumn 16, Issue 6, 2010, Pages 1061-1062

  Stadnyk, Andrew W ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN SULFATE; FAS LIGAND; GAMMA INTERFERON; TRINITROBENZENESULFONIC ACID;

APOPTOSIS; CELL PROTECTION; COLITIS; EDITORIAL; ENTERITIS; EPITHELIUM CELL; INTESTINE EPITHELIUM; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; ANTIGENS, CD95; APOPTOSIS; COLITIS; FAS LIGAND PROTEIN; HUMANS; INTESTINAL MUCOSA; MICE;

EID: 77952692437     PISSN: 10780998     EISSN: 15364844     Source Type: Journal    
DOI: 10.1002/ibd.21197     Document Type: Editorial

References (12)

1. Iwamoto M, Koji T, Makiyama K, et al. Apoptosis of crypt epithelial cells in ulcerative colitis. J Pathol. 1996;180:152-159. (Pubitemid 26370180)
2. Di Sabatino A, Ciccocioppo R, Luinetti O, et al. Increased enterocyte apoptosis in inflamed areas of Crohn's disease. Dis Colon Rectum. 2003;46:1498-1507. (Pubitemid 37429731)
3. Chen L, Park S-M, Turner J, et al. Cell death in the colonic epithelium during inflammatory bowel diseases: CD95/Fas and beyond. Inflam Bowel Dis. this issue.
4. Park S-M, Chen L, Zhang M, et al. CD95 is cytoprotective for intestinal epithelial cells in colitis. Inflam Bowel Dis. this issue.
5. Fuss IJ, Marth T, Neurath MF, et al. Anti-interleukin 12 treatment regulates apoptosis of Th1 T cells in experimental colitis in mice. Gastroenterology. 1999;117:1078-1088. (Pubitemid 29512666)
6. Sayani FA, Keenan CM, van Sickle MD, et al. The expression and role of Fas ligand in intestinal inflammation. Neurogastroenterol Motil. 2004;16:61-74. (Pubitemid 38253523)
7. Xiao S, Sung SJ, Fu SM, et al. Combining Fas mutation with interleukin-2 deficiency prevents colitis and lupus. Implicating interleukin-2 for auto-reactive T cell expansion and fas ligand for colon epithelial cell death. J Biol Chem. 2003;278:52730-52738. (Pubitemid 38035870)
8. Reardon C, Wang A, McKay DM. Transient local depletion of Foxp3+ regulatory T cells during recovery from colitis via Fas/Fas ligand-induced death. J Immunol. 2008;180:8316-8326.
9. O'Connell J, Bennett MW, O'Sullivan GC, et al. Fas counter-attack - the best form of tumor defense? Nat Med. 1999;5:267-268.
10. Ito R, Shin-Ya M, Kishida T, et al. Interferon-gamma is causatively involved in experimental inflammatory bowel disease in mice. Clin Exp Immunol. 2006;146:330-338. (Pubitemid 44581349)
11. Farooq SM, Stillie R, Svensson M, et al. Therapeutic effect of blocking CXCR2 on neutrophil recruitment and dextran sodium sulfate-induced colitis. J Pharmacol Exp Ther. 2009;329:123-129.
12. Edelblum KL, Washington MK, Koyama T, et al. Raf protects against colitis by promoting mouse colon epithelial cell survival through NF-kappaB. Gastroenterology. 2008;135:539-551.